COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy and Safety of COVID-19 Convalescent Plasma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04397523
Recruitment Status : Recruiting
First Posted : May 21, 2020
Last Update Posted : May 22, 2020
University Clinic for Infectious Diseases, North Macedonia
Information provided by (Responsible Party):
Institute for Transfusion Medicine of RNM

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 29, 2021
Estimated Study Completion Date : April 29, 2021
Huaxia, (2020). 'China puts 245 COVID-19 patients on convalescent plasma therapy',, 2 February. Available at: Accessed on March 30,2020
Guidance on collection, testing, processing, storage, distribution and monitored use. An EU programme of COVID-19 convalescent plasma collection and transfusion. EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY, 08 April, 2020
AABB's CCP Collection Protocol - Donor Eligibility, Processing, Labeling and Distribution, 03 April, 2020